• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-08-01

  This study demonstrates that ALDH2 activation, through pharmacological agents such as Alda 1, significantly enhances cardiomyocyte proliferation and delays the progression of pressure overload-induced heart failure in mice. These findings position ALDH2 as a novel target for cardiac regeneration, with important implications for cardioprotection in ischemia and heart failure models.

• Ibotenic Acid (SKU B6246): Precision Tool for Neurodegenerat

  2026-07-31

  This article delivers scenario-driven guidance for researchers using Ibotenic acid (SKU B6246) as an NMDA receptor agonist in neurodegenerative disease models. Drawing from recent literature and validated product data, it details best practices for experimental design, protocol optimization, and vendor selection to ensure reproducibility and robust results.

• Dutasteride (SKU A1659): Reliable Assays for Prostate Resear

  2026-07-31

  This comprehensive article addresses real-world laboratory challenges in cell viability and prostate disease modeling, clarifying how Dutasteride (SKU A1659) overcomes common hurdles in assay reproducibility, apoptosis quantification, and workflow optimization. Scenario-driven Q&A blocks provide actionable solutions and protocol insights for biomedical researchers seeking robust data with APExBIO’s Dutasteride.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via CaMKII P

  2026-07-30

  Li et al. (2025) reveal that P2RX1 overexpression in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) enhances mitochondrial apoptosis by activating Ca2+/CaMKII and suppressing PI3K/Akt signaling. This mechanistic insight identifies P2RX1 as a potential therapeutic target and underscores the need for robust apoptosis detection in translational leukemia research.

• NP-40 Lysis Buffer: Advancing Native Protein Complex Researc

  2026-07-30

  Explore how NP-40 Lysis Buffer enables high-fidelity extraction of native protein complexes from diverse cell types. This cornerstone article delivers in-depth scientific insight into non-denaturing lysis strategies and their impact on neuroimmunology and protein interaction studies.

• Thymoquinone Mitigates Doxorubicin Cardiotoxicity via Nrf2/H

  2026-07-29

  This study provides the first direct evidence that thymoquinone (2-isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione) protects murine hearts from doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 pathway and reducing ferroptosis. These findings clarify a mechanistic basis for thymoquinone’s cardioprotective effects and establish new parameters for cardiovascular toxicity modeling.

• Indazole-Based Glucagon Receptor Antagonists: Synthesis and

  2026-07-29

  This article examines the innovation and medicinal chemistry underpinning the discovery of a novel series of indazole- and indole-based glucagon receptor antagonists for type 2 diabetes. The reference study advances synthetic strategies for potent amide-linked drug candidates, highlighting implications for minimizing epimerization during amide bond formation in pharmaceutical development.

• Distinct Roles of ERK5 and ERK1/2 in Vitamin D3-Induced AML

  2026-07-28

  This study uncovers how the ERK5 MAPK pathway distinctly regulates the terminal differentiation and cell cycle arrest of acute myeloid leukemia (AML) cells in response to 1α,25-dihydroxyvitamin D3. By dissecting the interplay between ERK5 and ERK1/2 signaling, the research identifies new targets for optimizing differentiation-based leukemia therapies.

• Itraconazole: Triazole Antifungal Agent for Candida Research

  2026-07-28

  Itraconazole is a triazole antifungal agent with proven in vitro and in vivo efficacy against Candida species, notably Candida glabrata. Its dual role as a CYP3A4 inhibitor and hedgehog pathway modulator enables advanced antifungal drug interaction studies and research into biofilm resistance mechanisms.

• ABT-737 and the Next Generation of BCL-2 Inhibition in Cance

  2026-07-27

  This thought-leadership article explores the mechanistic underpinnings and strategic implications of targeting the BCL-2 protein family with ABT-737. Integrating new insights from super-resolution microscopy and translational research, it offers actionable guidance for leveraging apoptosis induction in cancer models. The article bridges foundational science with protocol best practices, competitive context, and forward-looking perspectives—anchoring its discussion in both recent literature and emerging industry standards.

• Zoledronic Acid: Rethinking Cancer and Bone Disease Research

  2026-07-27

  This thought-leadership article reframes zoledronic acid not only as a canonical antiresorptive agent, but as a mechanistically precise, translationally versatile tool for oncology and bone research. By integrating advanced mechanistic insights, protocol strategy, and competitive context, it equips translational scientists with actionable guidance and a forward-looking vision—bridging current literature and unexplored domains.

• Fluorimetric Analysis of Merbromin–Trypsin Binding Mechanism

  2026-07-26

  This study presents a detailed fluorimetric investigation of the interaction between Merbromin (Mercury dibromofluorescein disodium salt) and bovine trypsin. By combining steady-state and time-resolved fluorescence techniques, the authors quantify static fluorescence quenching, binding constants, and microenvironmental changes, providing a robust approach for protein–ligand interaction analysis.

• Fulvestrant (ICI 182,780): Transforming Endocrine Resistance

  2026-07-25

  Explore how Fulvestrant (ICI 182,780) empowers translational research by targeting estrogen receptor signaling and MDM2 protein degradation, redefining experimental and clinical strategies in advanced breast cancer and beyond.

• Mdivi-1 and the Gut–Mitochondria Axis: Beyond Mitochondrial

  2026-07-24

  Explore how Mdivi-1, a selective DRP1 inhibitor, modulates mitochondrial dynamics and apoptosis through the gut–mitochondria axis. This article reveals novel insights from recent co-metabolomics research and offers advanced guidance for mitochondrial dynamics research.

• Catalpol Mitigates Sepsis-Associated Cognitive Impairment vi

  2026-07-24

  This study demonstrates that Catalpol attenuates LPS-induced cognitive impairment in mice by inhibiting NF-κB-driven neuroinflammation and enhancing TrkB-mediated BDNF secretion. The findings offer mechanistic clarity and protocol-relevant insights for neuroprotection research in sepsis-associated encephalopathy models.

446 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page